Topical steroids versus PUVA therapy in moderate plaque psoriasis: A clinical trial along with cost analysis

By Amirnia Mehdi   Khodaeiani Effat   Fouladi Rohollah Fadaei   Hashemi Ali  

Journal of Dermatological Treatment, Vol. 23, Iss. 2, 2012-04 ,pp. : 109-111

Informa Healthcare

Access to resources Recommend Favorite

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

By Au Shiu-Chung  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan

By Igarashi Atsuyuki   Kuwabara Hiroyo   Fahrbach Kyle   Schenkel Brad  

Journal of Dermatological Treatment, Vol. 24, Iss. 5, 2013-10 ,pp. : 351-355

Informa Healthcare

Access to resources Recommend Favorite

Long-term response to etanercept monotherapy in moderate to severe psoriasis: assessment in daily practice by the maintenance of low values of PASI and BSA

By Fernández-Torres Rosa María   Paradela Sabela   Fonseca Eduardo  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 54-56

Informa Healthcare

Access to resources Recommend Favorite

Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2

By Reich Kristian   Schenkel Brad   Zhao Ning   Szapary Philippe   Augustin Matthias   Bourcier Marc   Guenther Lyn   Langley Richard G.  

Journal of Dermatological Treatment, Vol. 22, Iss. 6, 2011-12 ,pp. : 337-347

Informa Healthcare

Access to resources Recommend Favorite